ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

9,288Medicare Part D Prescriptions Filled, Including Refills

Rank: 129 out of 1006

$792K Total Retail Price of All Prescriptions

Rank: 82 out of 1006

609 Patients Receiving at Least One Drug in Part D
92%Patients 65 Years and Older
52% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Connecticut
Lower avg

Schedule Two
Controlled Substances

3% of this provider’s 609 patients filled at least one prescription for a schedule two drug, compared to an average of 4%.

Schedule Three
Controlled Substances

6% of this provider’s 609 patients filled at least one prescription for a schedule three drug, compared to an average of 4%.

Risky Drugs to Seniors

2% of this provider’s 8,760 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

27% of this provider’s prescriptions were for brand-name drugs, compared to an average of 29%.

Prescription Price

$85 was the average price of a prescription from this provider, compared to $71 among peers.

Prescriptions per Patient

15 is the average number of prescriptions (including refills) per patient, compared to an average of 18.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Connecticut
SIMVASTATIN 482 461 1 1
LISINOPRIL 314 294 2 3
LEVOTHYROXINE SODIUM 278 267 3 2
FUROSEMIDE 274 256 4 6
ATORVASTATIN CALCIUM 267 260 5 5
OMEPRAZOLE 199 190 6 9
HYDROCODONE-ACETAMINOPHEN 191 191 S3 7 25
AMLODIPINE BESYLATE 185 182 8 4
ZOLPIDEM TARTRATE 172 157 9 14
METOPROLOL SUCCINATE 164 154 10 12
METFORMIN HCL 161 151 11 10
DONEPEZIL HCL 151 151 12 17
CRESTOR 141 134 13 18
METFORMIN HCL ER 136 128 14 56
WARFARIN SODIUM 132 132 15 8
METOPROLOL TARTRATE 126 111 16 7
CITALOPRAM HBR 112 99 17 24
DIOVAN 99 89 18 16
ESCITALOPRAM OXALATE 97 88 19 27
HYDROCHLOROTHIAZIDE 96 88 20 11
SPIRONOLACTONE 94 83 21 71
CLOPIDOGREL 88 86 22 46
AMLODIPINE BESYLATE-BENAZEPRIL 86 86 23 77
ADVAIR DISKUS 83 79 24 37
CEFACLOR 82 79 25 322
LIPITOR 80 76 26 47
VYTORIN 79 64 27 145
POTASSIUM CHLORIDE 77 77 28 30
GLIPIZIDE ER 75 75 29 108
ATENOLOL 75 70 29 13
GLIPIZIDE XL 74 69 31 175
ZETIA 72 59 32 51
SYNTHROID 68 60 33 42
NAMENDA 68 68 33 34
PANTOPRAZOLE SODIUM 68 62 33 32
PLAVIX 64 62 36 61
PRAVASTATIN SODIUM 63 59 37 15
NEXIUM 63 53 37 28
JANUVIA 61 61 39 49
SERTRALINE HCL 61 57 39 19
PREDNISONE 59 56 41 33
ALENDRONATE SODIUM 58 58 42 29
MELOXICAM 58 57 42 67
LOVASTATIN 57 46 44 44
AZITHROMYCIN 57 49 44 39
CIPROFLOXACIN HCL 56 53 46 75
ALLOPURINOL 56 55 46 31
CARBIDOPA-LEVODOPA 56 56 46 80
GLIPIZIDE 56 55 46 69
TAMSULOSIN HCL 54 54 50 23
NAPROXEN 52 48 51 121
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Dec. 27, 2007.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.